Concern over a COVID-19-related BCG shortage.

Namkoong, H; Horita, N; Ebina-Shibuya, R

Namkoong, H; Horita, N; Ebina-Shibuya, R.

Affiliation

Namkoong H; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Horita N; Department of Pulmonology, Yokohama City University School of Medicine, Yokohama, Japan.
Ebina-Shibuya R; Laboratory of Molecular Immunology, Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA, <email></email>, Email: hounamugun@gmail.com.

Int J Tuberc Lung Dis ; 24(6): 642-643, 2020 Jun 01.

Article in En | MEDLINE | ID: mdl-32552997

Subject(s)

BCG Vaccine/supply & distribution; Coronavirus Infections/prevention & control; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; BCG Vaccine/therapeutic use; Betacoronavirus; COVID-19; Humans; SARS-CoV-2; Tuberculosis/prevention & control

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / BCG Vaccine / Coronavirus Infections / Pandemics Limits: Humans Language: En Journal: Int J Tuberc Lung Dis Year: 2020 Document type: Article Affiliation country: United States Country of publication: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google